Keyphrases
Acute Myeloid Leukemia
100%
Pediatric Leukemia
100%
Leukemia Therapy
100%
Western Kenya
100%
Clinical Characteristics
75%
Sociodemographic Characteristics
75%
Teaching Hospital
75%
Referral Hospital
75%
Chemotherapy
50%
High-income Countries
50%
Cytarabine
50%
Supportive Care
50%
Low-middle Income Countries
50%
Kenyan
50%
Abandonment Rate
50%
Treatment Protocol
25%
Event-free Survival
25%
Clinical Treatment
25%
Overall Survival
25%
Doxorubicin
25%
Etoposide
25%
Complete Remission
25%
Event Probability
25%
Start of Treatment
25%
Fluconazole
25%
Medical Records
25%
Antimicrobial Prophylaxis
25%
Median Time
25%
Treatment Outcome
25%
Symptom Duration
25%
Kenya
25%
Cotrimoxazole
25%
Eldoret
25%
Blood Products
25%
Early Death Rate
25%
Healthcare Optimization
25%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Pediatric Acute Myeloid Leukemia
100%
Patient Referral
75%
Supportive Care
50%
Cytarabine
50%
Low and Middle Income Countries
50%
Chemotherapy
50%
Disease
25%
Event Free Survival
25%
Overall Survival
25%
Doxorubicin
25%
Etoposide
25%
Antiinfective Agent
25%
Mortality Rate
25%
Medical Record
25%
Trimethoprim/Sulfamethoxazole
25%
Fluconazole
25%
Blood Product
25%